spacer
The Healthcare Sales & Marketing Network celebrates 24 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare News Roundup: BIopharmaceuticals

 HSMN NewsFeed - 21 Mar 2022
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Mar 2022
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of the BRIGHT Phase III Clinical Trial Evaluating PRX-102 for the Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 18 Mar 2022
NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Chief Financial Officer and Treasurer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2022
TC BioPharm Announces FDA Orphan Drug Status Granted for OmnImmune(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Mar 2022
Heron Therapeutics Announces Approval of ZYNRELEF(R) by Health Canada for the Management of Postoperative Pain
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 15 Mar 2022
Neuraxpharm appoints Tom Coogan as new Country Manager for Ireland
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2022
Dialectic Therapeutics Announces DT2216 Has Received Orphan Drug Designation from the FDA for the Treatment of T-Cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Mar 2022
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreements for Evaluation of Darovasertib and Crizotinib Combination in Metastatic Uveal Melanoma and Additional cMET-Driven Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Mar 2022
Terran Biosciences Announces Acquisition of a Portfolio of Novel CNS Therapeutics from Concert Pharmaceuticals
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 9 Mar 2022
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2022
Lyra Therapeutics Appoints Jim Tobin to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2022
Elixirgen Therapeutics Partners with Taisho Pharmaceutical on Therapeutics for Aging-Associated Diseases
Biopharmaceuticals
 HSMN NewsFeed - 4 Mar 2022
Lannett Announces Sale of Liquid Drug Manufacturing Plant and Other Assets for $10.5 Million
Biopharmaceuticals Generics
 HSMN NewsFeed - 3 Mar 2022
Inhibrx Receives FDA Orphan-Drug Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Mar 2022
RegeneRx Provides Regulatory Update Regarding RGN-259
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 2 Mar 2022
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 25 Feb 2022
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 25 Feb 2022
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA), from Bristol Myers Squibb
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Feb 2022
Gamifant (emapalumab) recommended for approval in China for treatment of primary haemophagocytic lymphohistiocytosis (HLH)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Feb 2022
PANTHERx(R) Rare Selected by Aadi Bioscience to Distribute FYARRO(TM) (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for Advanced Malignant Perivascular Epithelioid Cell Neoplasm (PEComa)
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 24 Feb 2022
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce the Submission of a Marketing Authorization Application to the European Medicines Agency for PRX-102 for the Treatment of Fabry Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Feb 2022
Abilita Bio Appoints Dan Bradbury to its Newly Formed Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Feb 2022
Plexium Announces $102M Financing To Advance Pipeline Of Targeted Protein Degradation Therapies And Technology Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 22 Feb 2022
TC Biopharm Announces Appointment of New Board Members
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Feb 2022
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2022
Biosion, Inc. Appoints Joel Edwards, MBA, as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Feb 2022
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2022
Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announces the FDA approval and availability of DHIVY(TM) for the treatment of Parkinson's disease
Biopharmaceuticals Neurology FDA Product Launch
 HSMN NewsFeed - 14 Feb 2022
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Feb 2022
Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2022
Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 10 Feb 2022
GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2022
ARS Pharmaceuticals Expands Executive Leadership Team with Addition of Pharmaceutical Commercialization Veterans
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2022
US FDA "Study May Proceed" Letter for Clarity's Cu-64 SAR-bisPSMA Trial in Prostate Cancer
Biopharmaceuticals Diagnostics Oncology FDA
 HSMN NewsFeed - 2 Feb 2022
Bexion Pharmaceuticals Announces Leadership Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2022
Pfizer and Alex Therapeutics announce a Strategic Commercial Partnership to provide evidence-based Digital Therapeutics to patients, starting in Germany
Biopharmaceuticals
Older BIopharmaceuticals stories   Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.